Targeting MondoA-TXNIP restores antitumour immunity in lactic-acid-induced immunosuppressive microenvironment

Nat Metab. 2025 Sep;7(9):1889-1904. doi: 10.1038/s42255-025-01347-1. Epub 2025 Aug 22.

Abstract

In the tumour microenvironment, accumulated lactic acid (LA) promotes tumour immune evasion by facilitating regulatory T cell (Treg) immunosuppressive function and restraining CD8+ T cell cytotoxicity, but the underlying mechanism remains elusive. Here we report that transcriptional factor MondoA-induced thioredoxin interacting protein (TXNIP) transcription is a common feature of both Treg and CD8+ T cells in response to lactic acid. In contrast to reduction in immunosuppressive capacity in MondoA-deficient Treg cells, loss of MondoA enhanced CD8+ T cell cytotoxic function in the lactic-acid-induced immunosuppressive microenvironment, by restoring glucose uptake and glycolysis. Mechanistically, lactic acid relied on sentrin/SUMO-specific protease 1 (SENP1) to stimulate the MondoA-TXNIP axis, which impaired TCR/CD28-signal-induced CD8+ T cell activation. Importantly, targeting the MondoA-TXNIP axis potentiated antitumour immunity in multiple cancer types and synergized with anti-PD-1 therapy to promote effective T cell responses in colorectal cancer. Our results demonstrate that the MondoA-TXNIP axis is a promising therapeutic target for improving cancer immunotherapy.

MeSH terms

  • Animals
  • CD8-Positive T-Lymphocytes / immunology
  • Carrier Proteins* / genetics
  • Carrier Proteins* / metabolism
  • Humans
  • Lactic Acid* / metabolism
  • Lactic Acid* / pharmacology
  • Mice
  • Mice, Inbred C57BL
  • Neoplasms / immunology
  • T-Lymphocytes, Regulatory / immunology
  • Transcription Factors* / metabolism
  • Tumor Microenvironment* / drug effects
  • Tumor Microenvironment* / immunology

Substances

  • Lactic Acid
  • Carrier Proteins
  • Transcription Factors